ExodusPoint Capital Management LP Invests $6.27 Million in Encompass Health Co. (NYSE:EHC)

ExodusPoint Capital Management LP bought a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 67,870 shares of the company's stock, valued at approximately $6,268,000. ExodusPoint Capital Management LP owned about 0.07% of Encompass Health at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB increased its position in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after buying an additional 137 shares in the last quarter. CBIZ Investment Advisory Services LLC grew its position in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after purchasing an additional 127 shares during the period. Tompkins Financial Corp purchased a new stake in shares of Encompass Health during the fourth quarter worth about $46,000. V Square Quantitative Management LLC raised its position in shares of Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after purchasing an additional 177 shares during the last quarter. Finally, Signaturefd LLC boosted its holdings in Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after buying an additional 125 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Remove Ads

Encompass Health Stock Down 1.5 %

Encompass Health stock traded down $1.57 during mid-day trading on Thursday, hitting $101.63. The company had a trading volume of 345,493 shares, compared to its average volume of 655,667. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 1 year low of $78.53 and a 1 year high of $104.55. The stock has a market cap of $10.24 billion, a price-to-earnings ratio of 22.73, a PEG ratio of 2.31 and a beta of 0.87. The business has a fifty day moving average of $99.51 and a 200 day moving average of $97.93.

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, sell-side analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.67%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio (DPR) is presently 15.25%.

Insiders Place Their Bets

In related news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 2.10% of the stock is owned by insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. StockNews.com lowered Encompass Health from a "buy" rating to a "hold" rating in a research note on Thursday, April 3rd. Barclays increased their target price on shares of Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, February 7th. Royal Bank of Canada reiterated an "outperform" rating and issued a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. KeyCorp lifted their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research report on Monday, February 10th. Finally, William Blair reissued an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. One analyst has rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $107.67.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.